Oncolytics Biotech
ONCY
#9263
Rank
โ‚ฌ86.11 M
Marketcap
0,81ย โ‚ฌ
Share price
-4.78%
Change (1 day)
-2.59%
Change (1 year)

EPS for Oncolytics Biotech (ONCY)

EPS in 2025 (TTM): -0,26ย โ‚ฌ

According to Oncolytics Biotech 's latest financial reports the company's current EPS (TTM) is -0,25ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -0,25ย โ‚ฌ an increase over its 2023 EPS that were of -0,27ย โ‚ฌ.

EPS history for Oncolytics Biotech from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-0,26ย โ‚ฌ6.11%
2024-0,25ย โ‚ฌ-7.57%
2023-0,27ย โ‚ฌ-2.45%
2022-0,27ย โ‚ฌ-17.58%
2021-0,33ย โ‚ฌ-12.46%
2020-0,38ย โ‚ฌ-61.76%
2019-0,99ย โ‚ฌ47.59%
2018-0,67ย โ‚ฌ-14.18%
2017-0,78ย โ‚ฌ-1.33%
2016-0,79ย โ‚ฌ11.83%
2015-0,71ย โ‚ฌ-52.2%
2014-1,48ย โ‚ฌ-31.2%
2013-2,15ย โ‚ฌ-45.51%
2012-3,94ย โ‚ฌ19.76%
2011-3,29ย โ‚ฌ25.91%
2010-2,61ย โ‚ฌ-2.52%
2009-2,68ย โ‚ฌ-4.93%
2008-2,82ย โ‚ฌ-11.64%
2007-3,19ย โ‚ฌ-235.81%
20062,35ย โ‚ฌ0.38%
20052,34ย โ‚ฌ-8.29%
20042,55ย โ‚ฌ49.76%
20031,70ย โ‚ฌ73.66%
20020,98ย โ‚ฌ-10.07%
20011,09ย โ‚ฌ-191.05%
2000-1,20ย โ‚ฌ115.84%
1999-0,56ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Aeterna Zentaris
AEZS
-1,76ย โ‚ฌ 591.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
17,62ย โ‚ฌ-7,024.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2,55ย โ‚ฌ-1,102.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
0,54ย โ‚ฌ-312.62%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
-0,72ย โ‚ฌ 183.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
-10,49ย โ‚ฌ 4,024.18%๐Ÿ‡บ๐Ÿ‡ธ USA